PwC Strategy& Analyst Interview: Complete Guide

Prompt: A diversified industrial holding company (eight business units across aerospace components, building products, water treatment, and industrial services — $6B combined revenue) is underperforming peers on EBITDA margin by 400 bps. The CEO asks whether to divest non-core units, rationalise shared services, or reinvest in growth. Where do you start?

How to structure: Strategy&'s home turf — capability-based strategy meets Fit for Growth cost transformation. Structure around (1) capability-coherence diagnostic — do the eight BUs share capabilities, or is the holding artificial? Units that don't share capabilities with the rest of the portfolio are divestiture candidates; (2) Fit for Growth cost analysis — separate good-cost (capability-building) from bad-cost (undifferentiated overhead) and identify the 400 bps gap by category; (3) reinvestment — redirect the 'bad-cost' harvest into the capabilities the coherent BUs need to win. End with a sequenced recommendation, not a one-shot decision.

What a strong answer sounds like: A strong candidate names capability-based strategy explicitly and applies it to the divestiture question — a BU is core if it shares capabilities with the rest of the portfolio, not just because it's profitable. They reference the Fit for Growth good-cost / bad-cost distinction and identify which cost buckets are likely driving the 400 bps gap. They end with a capability-coherent portfolio ('these four BUs share X capability system; divest the other four over 24 months') rather than a generic 'focus on the highest-margin units'.

Common weakness: Mediocre answers rank BUs by EBITDA margin and recommend divesting the lowest-margin units, which misses the entire capability-coherence thesis Strategy& is known for. They also conflate Fit for Growth with 'cost-cutting across the board' rather than the good-cost / bad-cost surgical approach.

Source: https://www.strategyand.pwc.com/gx/en/insights/fit-for-growth.html

Prompt: A PE fund is acquiring a $1.1B enterprise-software business at a 15x EBITDA multiple and wants a Deals Strategy review before signing. The target has strong logo retention but the fund is concerned about the five-year growth story. What's your approach?

How to structure: Strategy&'s Deals Strategy practice case. Structure around (1) commercial diagnostic — is the 15x multiple defensible given the growth profile and capability set?; (2) growth-story stress test — product roadmap, TAM expansion, sales capacity, capability gaps the PE fund would need to close; (3) value-creation plan — which capability investments move the exit multiple most, and what's the sequencing? Deals Strategy at PwC is capability-coherence analysis applied to M&A — the same lens used on operating strategy, turned toward deal underwriting.

What a strong answer sounds like: A strong answer explicitly reaches for Deals Strategy / commercial due diligence framing and applies the capability lens to the growth story — can the target credibly build the capabilities needed to hit the underwritten growth rate? They separate recurring-ARR quality (logo retention, NRR, churn) from growth-story risk (pipeline, win rate, capability gaps) and end with a view on whether the 15x holds, what capability capex is required, and what the value-creation plan looks like.

Common weakness: Weak answers treat this as a generic PE diligence case and skip the capability-coherence lens that distinguishes Strategy& from EY-P or L.E.K. They also commonly confuse ARR quality with growth-story risk and end up recommending 'the 15x is fine because retention is strong' — which ignores that multiples compress when growth decelerates regardless of retention.